PMC6859956_01
Patient's imaging pictures.
OTT-12-9663-g0001.jpg
PMC6859956_01_OTT-12-9663-g0001.jpg
F0001
TTF-1+, broad-spectrum CK+, CK5/6-, P63 and Ki-67 (70-80%) (Figure 1). A lymph node biopsy showed mixed small-cell carcinoma and large-cell neuroendocrine carcinoma (Figure 1).
The above is the test result of the patient. (A). The figure shows the patient's chest enhancement CT from 2013-12-8 to 2015-6-8, showing changes in primary lesions and mediastinal lymph node metastasis. (B). The figure shows the changes in tumor markers after the patient started treatment, especially after the application of the CAPTEM program in 2015-3-18, the NES decreased significantly, which suggests the superiority of CAPTEM. (C). CT shows the metastasis of cervical lymph nodes in patients with tumors. (D). In the figure, MRI shows the metastasis of the retroperitoneal lymph nodes in patients with tumors.
OTT-12-9663-g0002.jpg
PMC6859956_01_OTT-12-9663-g0002.jpg
F0002
The changes of CT, MRI and tumor marker of the patient are shown in Figure 2.